Gilead Sciences, Inc.
Toll like receptor modulator compounds
Last updated:
Abstract:
This application relates generally to toll like receptor modulator compounds and pharmaceutical compositions which, among other things, modulate toll-like receptors (e.g. TLR8), and methods of making and using them.
Status:
Grant
Type:
Utility
Filling date:
31 Aug 2017
Issue date:
6 Aug 2019